Celgene Inc. et al. v Dr. Reddy's Laboratories Ltd et al.
2025
T-1143-17
Resolved
18.1 PM(NOC) Regulations
Application under s.18.1 of the Patented Medicines (Notice of Compliance) Regulations regarding lenalidomide.
Counsel to:
Dr. Reddy's Laboratories Ltd.
The decision is reported
here.
Meet the team.

Carol Hitchman
Counsel
